Patents by Inventor Anthony Schaeffer

Anthony Schaeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210023109
    Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).
    Type: Application
    Filed: September 29, 2020
    Publication date: January 28, 2021
    Inventors: Stephen F. Murphy, Praveen Thumbikat, Anthony Schaeffer
  • Patent number: 10799520
    Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: October 13, 2020
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Stephen F. Murphy, Praveen Thumbikat, Anthony Schaeffer
  • Publication number: 20180280419
    Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).
    Type: Application
    Filed: March 16, 2018
    Publication date: October 4, 2018
    Inventors: Stephen F. Murphy, Praveen Thumbikat, Anthony Schaeffer
  • Publication number: 20160144012
    Abstract: The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity.
    Type: Application
    Filed: February 1, 2016
    Publication date: May 26, 2016
    Inventors: David Klumpp, Anthony Schaeffer, Benjamin Billips
  • Patent number: 9248175
    Abstract: The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: February 2, 2016
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: David Klumpp, Anthony Schaeffer, Benjamin Billips
  • Publication number: 20140234369
    Abstract: The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: David Klumpp, Anthony Schaeffer, Benjamin Billips
  • Patent number: 8709444
    Abstract: The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: April 29, 2014
    Assignee: Northwestern University
    Inventors: David Klumpp, Anthony Schaeffer, Benjamin Kyle Billips
  • Publication number: 20120093869
    Abstract: The present invention relates to compositions and methods for disease treatment and prevention through administration of a live attenuated composition. In particular, the present invention provides compositions and methods for the treatment and prevention of urinary tract infection by administration of a live attenuated compositions lacking O-antigen ligase activity.
    Type: Application
    Filed: May 14, 2010
    Publication date: April 19, 2012
    Inventors: David Klumpp, Anthony Schaeffer, Benjamin Billips
  • Publication number: 20050277140
    Abstract: The present invention provides biomarkers of chronic pelvic pain syndrome for use in diagnosis, drug screening, therapy monitoring, research and therapeutic applications. In particular, the present invention provides MCP-1 and MIP-1? as biomarkers of chronic pelvic pain syndrome.
    Type: Application
    Filed: April 27, 2005
    Publication date: December 15, 2005
    Applicant: Northwestern University
    Inventors: Anthony Schaeffer, Alisa Koch